Tenon Medical, Inc. (TNON)

TENON Medical, Inc. (TNON) stock has experienced volatility and a decline over the past six months. As of March 27, 2026, the stock price was $0.70 per share, a 66.82% decrease from March 31, 2025. Key events include the Q4 2025 earnings report with record revenue, FDA clearance for SImmetry+, a private placement of senior convertible notes for $4.3 million, and daily/weekly stock fluctuations.

Information detailing the demand seasonality for TENON Medical, Inc.'s products and services is not explicitly available. However, stock price seasonality analysis suggests October has the highest probability of positive stock return, while March has the lowest.

TENON Medical, Inc. (TNON) is a medical device company focused on surgical solutions for sacroiliac (SI) joint and sacro-pelvic disorders. Founded in 2012 and based in Los Gatos, California, it operates in the Healthcare sector, specifically in the Medical Devices & Instruments industry. The company develops and commercializes minimally invasive SI joint fusion systems, including the Catamaran SI Joint Fusion System and the SImmetry+ SI-Joint Fusion System. The Catamaran system offers a less invasive approach using a single titanium implant, while the SImmetry+ system provides a complementary lateral approach.

TENON Medical, Inc. is headquartered in Los Gatos, California, and has a Swiss subsidiary. The company's primary market focus appears to be the United States, and it operates with a unified operational and financial approach.

TENON Medical's brand reputation is positively influenced by its product development and commercialization efforts. Management's tone and analyst questions following the Q4 2025 earnings call reflected growing confidence in the company's execution. The FDA clearance for the SImmetry+ SI-Joint Fusion System and the expanded use of the Catamaran system are significant positive developments.

TENON Medical, Inc. (US:TNON) has 18 institutional owners and shareholders holding a total of 431,629 shares. Major institutional owners include Vanguard Group Inc., DRW Securities, LLC, and Geode Capital Management, Llc. Institutional investors own 22.74% of Tenon Medical's stock.